+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Esophageal Squamous Cell Carcinoma - Pipeline Insight, 2022 - Product Thumbnail Image

Global Esophageal Squamous Cell Carcinoma - Pipeline Insight, 2022

  • Clinical Trials
  • August 2022
  • 150 Pages
  • Global
From
From
From
From
Mantle Cell Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Mantle Cell Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 80 Pages
  • Global
From
Diffuse Large B-Cell Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Diffuse Large B-Cell Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 240 Pages
  • Global
From
From
From
From
From
Follicular Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Follicular Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Indolent Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Indolent Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Waldenstrom Macroglobulinemia - Pipeline Insight, 2024 - Product Thumbnail Image

Waldenstrom Macroglobulinemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Refractory Multiple Myeloma - Pipeline Insight, 2024 - Product Thumbnail Image

Refractory Multiple Myeloma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Chronic lymphocytic leukemia - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic lymphocytic leukemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 210 Pages
  • Global
From
CD137 Antibodies Clinical Trials & Market Opportunity Insight 2027 - Product Thumbnail Image

CD137 Antibodies Clinical Trials & Market Opportunity Insight 2027

  • Report
  • September 2024
  • 210 Pages
  • Global
From
From
Loading Indicator